Table 2.

Comparison between mean aspartate aminotransferase, alanine aminotransferase, and alkaline phosphatase on different days in silymarin and placebo groups

Variables	Day	Silymarin	Placebo	P-value
AST (U/l)	Baseline	215.14 ±91.61	201.88 ±65.78	0.43
	Day 3	180.42 ±85.22	197.48 ±58.31	0.27
	Day 7	144.24 ±73.37	184.93 ±57.02	0.04
	Day 9	111.33 ±61.43	161.37 ±55.01	< 0.001
	Day 14	79.26 ±49.95	133.97 ±52.94	< 0.001
ALT (U/l)	Baseline	181.84 ±81.59	178.22 ±65.78	0.81
	Day 3	149.15 ±74.19	176.04 ±55.50	0.055
	Day 7	116.55 ±63.39	164.82 ±55.19	0.062
	Day 9	84.86 ±52.28	138.73 ±53.63	< 0.001
	Day 14	58.75 ±42.10	112.75 ±51.39	< 0.001
ALP (U/l)	Baseline	272.15 ±44.06	268.05 ±54.11	0.79
	Day 3	254.15 ±42.09	258.70 ±50.77	0.75
	Day 7	222.40 ±39.19	252.30 ±49.68	0.041
	Day 9	197.60 ±39.42	229.07 ±50.80	0.027
	Day 14	154.80 ±40.11	209.45 ±49.69	< 0.001

AST – aspartate aminotransferase, ALT – alanine transaminase, ALP – alkaline phosphatase